# Reduced medical costs and hospital days when using oral arsenic plus ATRA as the first-line treatment of acute promyelocytic leukemia

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/reduced-medical-costs-and-hospital-days-when-using-oral-arsenic-plus-atra-as-the/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hao Jiang,Gong‐Wen Liang,Xiao‐Jun Huang,Qian Jiang,Sheng Han,Luwen Shi,Hong‐Hu Zhu |
| Citations | 29 |
| DOI | 10.1016/j.leukres.2015.09.007 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1826104083 |
| PMID | 26403986 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Sheng Han](https://scholariq.org/researchers/sheng-han/)

## Paper journal

- [Leukemia Research](https://scholariq.org/journals/leukemia-research/)

## Paper primary topic

- [Retinoids in leukemia and cellular processes](https://scholariq.org/topics/retinoids-in-leukemia-and-cellular-processes/)

## Paper topics

- [Retinoids in leukemia and cellular processes](https://scholariq.org/topics/retinoids-in-leukemia-and-cellular-processes/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Antioxidant Activity and Oxidative Stress](https://scholariq.org/topics/antioxidant-activity-and-oxidative-stress/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.